NZ501427A - Vaccine compositions comprising the Helicobacter pylori FlgE (flagella) polypeptide and a mucosal adjuvant - Google Patents
Vaccine compositions comprising the Helicobacter pylori FlgE (flagella) polypeptide and a mucosal adjuvantInfo
- Publication number
- NZ501427A NZ501427A NZ501427A NZ50142798A NZ501427A NZ 501427 A NZ501427 A NZ 501427A NZ 501427 A NZ501427 A NZ 501427A NZ 50142798 A NZ50142798 A NZ 50142798A NZ 501427 A NZ501427 A NZ 501427A
- Authority
- NZ
- New Zealand
- Prior art keywords
- helicobacter pylori
- polypeptide
- flagella
- mucosal adjuvant
- vaccine compositions
- Prior art date
Links
- 241000590002 Helicobacter pylori Species 0.000 title abstract 3
- 229940037467 helicobacter pylori Drugs 0.000 title abstract 3
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 239000002671 adjuvant Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 210000003495 flagella Anatomy 0.000 title 2
- 206010019375 Helicobacter infections Diseases 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56922—Campylobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702242A SE9702242D0 (sv) | 1997-06-12 | 1997-06-12 | Vaccine compositions V |
| PCT/SE1998/001093 WO1998056816A1 (en) | 1997-06-12 | 1998-06-08 | VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI FlgE POLYPEPTIDE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ501427A true NZ501427A (en) | 2000-09-29 |
Family
ID=20407351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ501427A NZ501427A (en) | 1997-06-12 | 1998-06-08 | Vaccine compositions comprising the Helicobacter pylori FlgE (flagella) polypeptide and a mucosal adjuvant |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1009764A1 (xx) |
| JP (1) | JP2002507118A (xx) |
| KR (1) | KR20010013699A (xx) |
| CN (1) | CN1259960A (xx) |
| AR (1) | AR012896A1 (xx) |
| AU (1) | AU8048798A (xx) |
| BR (1) | BR9810026A (xx) |
| CA (1) | CA2293293A1 (xx) |
| EE (1) | EE9900566A (xx) |
| HU (1) | HUP0003164A3 (xx) |
| ID (1) | ID23052A (xx) |
| IL (1) | IL133144A0 (xx) |
| IS (1) | IS5288A (xx) |
| NO (1) | NO996132L (xx) |
| NZ (1) | NZ501427A (xx) |
| PL (1) | PL337503A1 (xx) |
| SE (1) | SE9702242D0 (xx) |
| SK (1) | SK173099A3 (xx) |
| TR (1) | TR199903060T2 (xx) |
| WO (1) | WO1998056816A1 (xx) |
| ZA (1) | ZA984696B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104784687A (zh) * | 2015-04-27 | 2015-07-22 | 苏州大学附属第一医院 | 重组绿脓杆菌鞭毛钩蛋白FlgE的用途 |
| CN113425717B (zh) * | 2021-04-22 | 2023-06-16 | 成都欧林生物科技股份有限公司 | 一种提高口服幽门螺杆菌疫苗效力的药剂及其应用 |
| CN116535472B (zh) * | 2023-05-31 | 2024-04-30 | 四川大学华西医院 | 一种幽门螺杆菌重组蛋白抗原FlgK及其制备方法与应用 |
| CN118105473B (zh) * | 2024-04-30 | 2024-08-16 | 成都欧林生物科技股份有限公司 | 一种预防或治疗Hp感染口服免疫原性组合物及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5459041A (en) * | 1988-02-18 | 1995-10-17 | Enteric Research Laboratories, Inc. | Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection |
| AR003125A1 (es) * | 1995-06-01 | 1998-07-08 | Astra Ab | Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la |
-
1997
- 1997-06-12 SE SE9702242A patent/SE9702242D0/xx unknown
-
1998
- 1998-06-01 ZA ZA984696A patent/ZA984696B/xx unknown
- 1998-06-01 AR ARP980102558A patent/AR012896A1/es unknown
- 1998-06-08 SK SK1730-99A patent/SK173099A3/sk unknown
- 1998-06-08 EE EEP199900566A patent/EE9900566A/xx unknown
- 1998-06-08 EP EP98928772A patent/EP1009764A1/en not_active Withdrawn
- 1998-06-08 CA CA002293293A patent/CA2293293A1/en not_active Abandoned
- 1998-06-08 PL PL98337503A patent/PL337503A1/xx unknown
- 1998-06-08 IL IL13314498A patent/IL133144A0/xx unknown
- 1998-06-08 CN CN98806101A patent/CN1259960A/zh active Pending
- 1998-06-08 NZ NZ501427A patent/NZ501427A/xx unknown
- 1998-06-08 AU AU80487/98A patent/AU8048798A/en not_active Abandoned
- 1998-06-08 KR KR1019997011714A patent/KR20010013699A/ko not_active Application Discontinuation
- 1998-06-08 ID IDW991542A patent/ID23052A/id unknown
- 1998-06-08 TR TR1999/03060T patent/TR199903060T2/xx unknown
- 1998-06-08 HU HU0003164A patent/HUP0003164A3/hu unknown
- 1998-06-08 JP JP50228399A patent/JP2002507118A/ja active Pending
- 1998-06-08 WO PCT/SE1998/001093 patent/WO1998056816A1/en not_active Application Discontinuation
- 1998-06-08 BR BR9810026-2A patent/BR9810026A/pt not_active IP Right Cessation
-
1999
- 1999-12-08 IS IS5288A patent/IS5288A/is unknown
- 1999-12-10 NO NO996132A patent/NO996132L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO996132L (no) | 2000-01-28 |
| BR9810026A (pt) | 2000-09-19 |
| JP2002507118A (ja) | 2002-03-05 |
| NO996132D0 (no) | 1999-12-10 |
| WO1998056816A1 (en) | 1998-12-17 |
| EP1009764A1 (en) | 2000-06-21 |
| AU8048798A (en) | 1998-12-30 |
| PL337503A1 (en) | 2000-08-28 |
| CA2293293A1 (en) | 1998-12-17 |
| IS5288A (is) | 1999-12-08 |
| CN1259960A (zh) | 2000-07-12 |
| ID23052A (id) | 2000-01-20 |
| HUP0003164A2 (hu) | 2000-12-28 |
| ZA984696B (en) | 1999-01-04 |
| HUP0003164A3 (en) | 2001-10-29 |
| TR199903060T2 (xx) | 2000-09-21 |
| EE9900566A (xx) | 2000-06-15 |
| SE9702242D0 (sv) | 1997-06-12 |
| SK173099A3 (en) | 2000-06-12 |
| AR012896A1 (es) | 2000-11-22 |
| KR20010013699A (ko) | 2001-02-26 |
| IL133144A0 (en) | 2001-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2176232T3 (es) | Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter. | |
| IL140217A0 (en) | Particles of hcv envelope proteins: use for vaccination | |
| ZA956412B (en) | Mutant enterotoxin effective as a non-toxic oral adjuvant | |
| ES8704350A1 (es) | Procedimiento para la preparacion de un conjugado bacteriano | |
| NZ323973A (en) | Vaccine compositions for intranasal administration comprising chitosan and use thereof | |
| GB2303854B (en) | Helicobacter proteins and vaccines | |
| GB9419979D0 (en) | Vaccine compositions | |
| HUP9801266A2 (hu) | Multimer, rekombináns ureázvakcina | |
| WO2002100340A3 (en) | Improved vaccination against anthrax | |
| HUP9801223A2 (hu) | Eljárás specifikus antigénekre adott antitest válasz fokozására interleukin-10-zel | |
| DE69828801D1 (de) | Peptide abgeleitet vom bindungs (g) protein des respiratorisches synzytialvirus | |
| NZ501427A (en) | Vaccine compositions comprising the Helicobacter pylori FlgE (flagella) polypeptide and a mucosal adjuvant | |
| HK1138516A1 (en) | Parenteral vaccine formulations and uses thereof | |
| ZA919907B (en) | Use of il-4 to enhance immune response to immunogens in vaccines | |
| AR010568A1 (es) | Polipeptido, composicion de vacuna, uso del polipeptido en la fabricacion de una composicion, y metodo para producir en un mamifero una respuestainmuno-protectora contra la infeccion de helicobacter pylori | |
| HK1025220A1 (en) | Novel saponin compositions and uses thereof | |
| IL97600A0 (en) | Use of il-4 to enhance immune response to infectious antigenic challenges | |
| CA2516661A1 (en) | M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever | |
| NZ224251A (en) | Synthetic rhinovirus (hrv) peptides and vaccines | |
| NO995290L (no) | Anti-helicobacter-vaksineblanding for anvendelse av den subdiafragmatiske systemiske ruten og kombinert mukosal/parenteral immuniseringsmetode | |
| SE9702240D0 (sv) | Vaccine compositions III | |
| RU98123839A (ru) | Вакцинная композиция, содержащая полипептид флагеллина helicobacter pylori | |
| Lindberg et al. | Cell-mediated immune reactivity against Salmonella antigens in enteric infection. | |
| Reznik et al. | A modern status of tick borrelioses foci in the south of the Turkmen SSR. | |
| TH34526A (th) | แอนติเจนจากแบคทีเรียและส่วนประกอบ ii ของวัคซีน |